Bell Rock Capital LLC Novartis Ag Transaction History

Bell Rock Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$70.67 - $99.01 $94,485 - $132,376	-1,337 Closed	0 $0
Q4 2019 Feb 03, 2020	SELL	$84.35 - $95.37 $421 - $476	-5 Reduced 0.37%	1,337 $127,000
Q2 2019 Jul 31, 2019	BUY	$75.4 - $92.8 $43,355 - $53,360	575 Added 74.97%	1,342 $0
Q1 2019 Apr 08, 2019	BUY	$75.32 - $86.15 $57,393 - $65,646	762 Added 15240.0%	767 $74,000
Q4 2018 Jan 25, 2019	BUY	$73.66 - $82.02 $368 - $410	5 New	5 $0

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Bell Rock Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bell Rock Capital LLC with notifications on news.